Augustine Andrea, Winstanley Catharine A, Krishnan Vaishnav
Department of BioSciences, Rice University, Houston, TX, United States.
Department of Psychology, Djavad Mowafaghian Centre for Brain Health, The University of British Columbia, Vancouver, BC, Canada.
Front Neurosci. 2021 Mar 12;15:654238. doi: 10.3389/fnins.2021.654238. eCollection 2021.
Parkinson's disease (PD) is a neurodegenerative disorder that is characterized by symptoms that impact both motor and non-motor domains. Outside of motor impairments, PD patients are at risk for impulse control disorders (ICDs), which include excessively disabling impulsive and compulsive behaviors. ICD symptoms in PD (PD + ICD) can be broadly conceptualized as a synergistic interaction between dopamine agonist therapy and the many molecular and circuit-level changes intrinsic to PD. Aside from discontinuing dopamine agonist treatment, there remains a lack of consensus on how to best address ICD symptoms in PD. In this review, we explore recent advances in the molecular and neuroanatomical mechanisms underlying ICD symptoms in PD by summarizing a rapidly accumulating body of clinical and preclinical studies, with a special focus on the utility of rodent models in gaining new insights into the neurochemical basis of PD + ICD. We also discuss the relevance of these findings to the broader problem of impulsive and compulsive behaviors that impact a range of neuropsychiatric syndromes.
帕金森病(PD)是一种神经退行性疾病,其特征是症状会影响运动和非运动领域。除了运动障碍外,帕金森病患者还面临冲动控制障碍(ICD)的风险,其中包括过度致残的冲动和强迫行为。帕金森病中的冲动控制障碍症状(PD + ICD)可以大致概念化为多巴胺激动剂治疗与帕金森病固有的许多分子和神经回路水平变化之间的协同相互作用。除了停止多巴胺激动剂治疗外,对于如何最好地解决帕金森病中的冲动控制障碍症状,目前仍缺乏共识。在这篇综述中,我们通过总结迅速积累的临床和临床前研究,探讨帕金森病中冲动控制障碍症状背后的分子和神经解剖学机制的最新进展,特别关注啮齿动物模型在深入了解PD + ICD神经化学基础方面的作用。我们还讨论了这些发现与影响一系列神经精神综合征的冲动和强迫行为这一更广泛问题的相关性。